Commentary · 27 May 2026
Conference abstractPublished 13 Sep 2017
Are incretins promoters or initiators of pancreatic cancer?
University of Nebraska Medical Center, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Recently, striking abnormalities in the insulin-ductuar cells of pancreas were reported in Type-2 diabetic patients treated with GLP-1-1 analog. Our studies revealed that these alterations were almost identical to the early neoplastic changes that occur in the hamster pancreatic cancer model. To confirm these similarities, we examined the pancreas of a Type-2 diabetic patient, who developed pancreatic cancer a year after the treatment with GLP-1 analogs. As in the hamster model, there were multifocal proliferation of insulin-ductular cells with atria and patterns consistent with in-situ carcinomas. The relevance of these findings and possible biological pathways will be discussed.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.
More from this journal
The newest in Pancreatic Disorders & Therapy.
Short communication · 27 May 2026
Immunometabolic Interactions in Pancreatic Disease: Crosstalk Between Energy Dysregulation, Immune Activation, and Tissue Dysfunction
Commentary · 27 May 2026
Microvascular Dysfunction in Pancreatic Disorders: Endothelial Injury, Perfusion Failure, and Tissue Consequences
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPancreatic Disorders & Therapy
- SubjectGastroenterology & Hepatology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Parviz M Pour”
